GlassScriptPhysician profile
Brian Dale Patten
NPI 1497946909
$276.37
in general payments reported to CMS, 2019-2025
11 companies · $14.42 in 2025
The $14.42 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.61 · 2020: $10.76 · 2021: $54.62 · 2022: $160 · 2025: $14.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $94.52 | 2022 | |
| Gc America INC. | $28.49 | 2022-2025 | Mi Paste, Equia, G-Aenial |
| Orapharma, A Division of Bausch Health US, LLC | $26.59 | 2021 | |
| Align Technology, INC. | $25.76 | 2022 | |
| Henry Schein, INC. | $23.11 | 2019 | |
| Implant Direct Sybron International LLC | $16.93 | 2021 | |
| Zimmer Biomet Holdings, INC. | $13.50 | 2019 | |
| Philips North America LLC | $13.13 | 2022 | |
| Ultradent Products INC | $12.48 | 2022 | |
| 3m Company | $11.10 | 2021 | |
| Ivoclar Vivadent, INC. | $10.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Patten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.